로딩 중…
지수 로딩 중…
DHP Korea Co., Ltd.
131030· KOSDAQ· Health Care· Health Care Equipment & Services
₩5,740-1.20%
2026-11-02
Financials
Valuation Metrics
DHP Korea Co., Ltd.'s Market Cap is ₩1013B. At end of 2025 it was ₩1214B. Ranked #1191 of 2,410 in KR market (top 49%), #634 of 1,631 on KOSDAQ (top 39%), #42 of 94 in Health Care Equipment & Services (top 45%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 101.29B KRW | KR#1,191/2,410 Sec#42/94 |
| Revenue | 94.47B KRW | KR#1,447/2,410 Sec#41/94 |
| Net Income | 13.75B KRW | KR#849/2,410 Sec#23/94 |
| Total Assets | 191.06B KRW | KR#1,346/2,410 Sec#37/94 |
| Net Assets | 165.01B KRW | KR#1,073/2,410 Sec#28/94 |
| Employees | 239 | KR#953/2,410 Sec#28/94 |
| Value | ||
| P/E | 7.37x | KR#674/2,410 Sec#18/94 |
| P/B | 0.61x | KR#1,085/2,410 Sec#20/94 |
| PEG | 0.17x | KR#541/2,410 Sec#24/94 |
| P/S | 1.07x | KR#1,500/2,410 Sec#36/94 |
| EV/EBITDA | 7.98x | KR#529/2,410 Sec#15/94 |
| FCF Yield | -27.93% | KR—/2,410 Sec—/94 |
| Profitability | ||
| ROE | 8.33% | KR#759/2,410 Sec#31/94 |
| ROA | 7.20% | KR#499/2,410 Sec#25/94 |
| Op. Margin | 10.70% | KR#482/2,410 Sec#28/94 |
| Revenue Growth | 14.08% | KR#716/2,410 Sec#37/94 |
| Earnings Growth | 44.65% | KR#578/2,410 Sec#26/94 |
| Financial Health | ||
| Debt Ratio | 15.79% | KR#266/2,410 Sec#16/94 |
| Total Debt | 0 KRW | KR—/2,410 Sec—/94 |
| FCF | -28.29B KRW | KR#1,969/2,410 Sec#75/94 |
| Cash | 20.67B KRW | KR#1,236/2,410 Sec#32/94 |
| Current Ratio | 4.03x | KR#375/2,410 Sec#27/94 |
| Net Debt/EBITDA | -2.05x | KR#233/2,410 Sec#5/94 |
| Dividend | ||
| Div. Yield | 1.51% | KR#1,043/2,410 Sec#31/94 |
| Div. Growth | 0.62% | KR#685/2,410 Sec#24/94 |
| Performance | ||
| 1Y Return | -17.77% | KR#1,007/2,410 Sec#25/94 |
| 1M Return | -8.01% | KR#565/2,410 Sec#19/94 |
| From 52W High | -72.34% | KR#2,113/2,410 Sec#83/94 |
| 1Y MDD | -74.56% | KR#2,131/2,410 Sec#85/94 |
| Trading | ||
| Volume | 12,184 shares | KR#1,782/2,410 Sec#75/94 |
| Trading Value | 70.0M KRW | KR#1,633/2,410 Sec#70/94 |
| Foreign Own. | 3.96% | KR#1,056/2,410 Sec#33/94 |
| Per Share | ||
| EPS | 779 KRW | KR#819/2,410 Sec#18/94 |
| BPS | 9,351 KRW | KR#1,046/2,410 Sec#23/94 |
Company Info
동사는 2010년 설립되어 2013년 디에이치피코리아와 합병하고, 2022년 옵투스제약으로 상호변경함. 눈 건조, 감염 등 안과 질환 예방 및 치료에 초점을 맞춘 점안액을 전문적으로 개발·제조하며, 안과 분야 전문 기업임. 2024년 신규공장 건축공사 착수로 연간 생산능력을 2026년까지 확대할 예정이며, AOA 교육 플랫폼 도입과 KAM 적용으로 제품 인지도 제고 및 거래처 관리 효율성을 개선하고 있음. 옵투스제약는 2010년에 설립되었으며 충청북도 청주시에 본사를 두고 있습니다.